Connect with us

Covid

Black Fungus cases grow 150% in 3 weeks

Published

on

Black Fungus cases grow 150% in 3 weeks

The first and second waves of Coronavirus have already created havoc in the country. Shockingly, the fear of black fungus among Covid-19 patients is increasing each day. Currently, there are 31,216 cases and 2109 deaths have been registered. In other words, the cases of black fungus have grown over 150 per cent over the last three weeks.

The increase in the cases is driven, in part, by severe shortage of the key drug – Amphotericin-B – to treat affected patients.

Maharashtra stands first in the list with 7057 cases and 609 deaths, followed by Gujarat with 5,418 cases and 323 deaths.

Rajasthan is the third state with 2,976 cases but Karnataka occupies third spot with 188 deaths.

Uttar Pradesh has reported 1744 cases and 142 deaths while the Delhi has logged 1,200 cases and 125 deaths.
At 96, Jharkhand has the least number of cases, while West Bengal with 23 has the lowest deaths.

Covid

Covid-19 in India: 18,987 new cases in last 24 hours, 20% higher than day before

Published

on

By

Covid-19 in India: 18,987 new cases in last 24 hours, 20% higher than day before

The Union Ministry of Health and Family Welfare (MoHFW) said on Wednesday said that India registered 18,987 new Covid-19 cases in the last 24 hours, which was 20 per cent higher than what the country had witnessed a day before.

Also, total of 246 deaths were reported during the same time, increasing the total reported death count to 4,51,435.

With this, the total Covid caseload in India has increased to 3,40,20,730.

The top five states which have registered maximum cases are Kerala with 11,079 cases, followed by Maharashtra with 2,219 cases, Tamil Nadu with 1,280 cases, Mizoram with 1,028 cases and West Bengal with 771 cases.

Continue Reading

Covid

Covaxin gets emergency use approval for kids aged 2-18 years

Published

on

By

Covaxin gets emergency use approval for kids aged 2-18 years

The Subject Expert Committee (SEC) on Covid-19 has granted emergency use approval to Bharat Biotech’s Covaxin for children in the 2-18 years age group.

In September, Hyderabad-based Bharat Biotech had completed Phase-2 and Phase-3 trials of Covaxin on children below 18 years of age and also submitted the trial data to the Drugs and Comptroller General of India (DCGI).

“After detailed deliberation, the committee recommended for grant of market authorization of the vaccine for the age group of 2 to 18 years for restricted use in emergency situation,” the subject expert panel said in a statement.

 

Continue Reading

Covid

Govt has no data of Covid-19 vaccines given daily by private hospitals

Published

on

By

Govt has no data of Covid-19 vaccines given daily by private hospitals

The Union health ministry has said that it does not hold data of daily Covid-19 vaccines doses administered by private hospitals and health service providers.

In a response to RTI petition and appeal filed by activist Commodore (Retd) Lokesh Batra, the government has said the same

In its first reply, the government mentioned, “Private hospitals/institutions etc procure vaccines directly from the vaccine manufacturers. Data asked pertains between manufacturers and private hospitals/institutions etc. Separate vaccination data is not available, however, the vaccination data ll date can be checked on the below link hps://dashboard.cowin.gov.in/ (sic).”

“This information is not maintained and is not available since procurement of vaccines by private hospitals private healthcare service providers and private entities are done directly from the manufacturers,” the Union health ministry said.

Continue Reading

Trending